Abstract:The gram-negative facultative intracellular pathogen Salmonella enterica serotype Choleraesuis, also known as S. Choleraesuis, is a major financial loss for the pig business. C500 is a vaccine strain that has been used for preventing S. Choleraesuis infection in pigs for many years in China. Although it possessed good immunogenicity and protection efficacy, it still showed severe side effects. The truncation of the key gene rpoS in C500 was believed to take the major responsibility for its attenuation. To achieve a good balance between attenuation and immunogenicity, rpoS was restored to an active state, and other essential virulent genes of crp, fur, phoP, and aroA were evaluated for their effects of deletion on safety and immunogenicity. Animal experiments demonstrated that C5001 (C500 rpoS+ Δcrp10) and C5002 (C500 rpoS+ Δfur9) showed an excellent ability to induce an immune response. To further decrease the endotoxic activity, the combination mutations of ΔpagL7 ΔpagP81::Plpp lpxE ΔlpxR9 were introduced into the mutant strains to generate 1′-dephosphorylated lipid A. Animal experiments showed that SC3 (C500 rpoS+ Δfur9 ΔpagL7 ΔpagP81:: Plpp lpxE ΔlpxR9) induced higher levels of IgG and secreted IgA antibodies and provided a higher protection rate than SC1 (C500 ΔpagL7 ΔpagP81:: Plpp lpxE ΔlpxR9) and SC2 (C500 rpoS+ Δcrp10 ΔpagL7 ΔpagP81:: PlpplpxE ΔlpxR9). We also evaluated the ability of SC3 (C500 rpoS+ Δfur9 ΔpagL7 ΔpagP81:: Plpp lpxE ΔlpxR9) as a vaccine carrier to deliver heterologous protein antigens and polysaccharide antigens. The results indicated that SC3 (C500 rpoS+ Δfur9 ΔpagL7 ΔpagP81:: Plpp lpxE ΔlpxR9) showed an excellent ability to deliver heterologous antigens and induce the host to produce high levels of antibodies. Together, these results indicate that we constructed a safe and efficient attenuated strain of the S. Choleraesuis vaccine, which demonstrated strong resistance to infection with wild-type S. Choleraesuis and can be employed as a universal vector for the delivery of recombinant antigens.

Construction, Characterization And Evaluation Of The Protective Efficacy Of The Streptococcus Suis Double Mutant Strain Delta Sspep/Delta Sspspc As A Live Vaccine Candidate In Mice

A Streptococcus suis Strain Δcps/ssna-msly (P353L)-SC19 Provides Cross-Protection against Serotypes 2 and 9 Strain Challenges in a Mouse Model

Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross protection against serotype 9 strain.

Progress Toward the Development of a Vaccine Against Streptococcus suis Capsular Type 2

Construction and Characterization of Streptococcus Suis Type 2 Mutant Strain with Suilysin Gene Deletion

O-acetyl-homoserine Sulfhydrylase Deficient Streptococcus Suis Serotype 2 Strain SC19 Becomes an Avirulent Strain and Provides Immune Protection Against Homotype Infection in Mice

A Serine/threonine Phosphatase 1 of Streptococcus Suis Type 2 is an Important Virulence Factor.

Construction and Identification of a Recombinant Attenuated Salmonella Expressing Streptococcus suis sly Gene

Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice

TLR4 Agonist Combined with Trivalent Protein JointS of <i>Streptococcus suis</i> Provides Immunological Protection in Animals

Generation and evaluation of Salmonella enterica serovar Choleraesuis mutant strains as a potential live-attenuated vaccine

Construction of RevS gene knock-out mutant of Streptococcus suis serotype 2]

A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suis

Stk and Stp1 Participate in Streptococcus Suis Serotype 2 Pathogenesis by Regulating Capsule Thickness and Translocation of Certain Virulence Factors.

Construction and Evaluation of an Efficient Live Attenuated Salmonella Choleraesuis Vaccine and Its Ability as a Vaccine Carrier to Deliver Heterologous Antigens

Inactivation of the Soda Gene of Streptococcus Suis Type 2 Encoding Superoxide Dismutase Leads to Reduced Virulence to Mice

Roles of the Putative Type IV-like Secretion System Key Component VirD4 and PrsA in Pathogenesis of Streptococcus Suis Type 2.

Construction and Characterization of a Streptococcus Suis Serotype 2 Recombinant Expressing Enhanced Green Fluorescent Protein.

PrsA Contributes to Streptococcus Suis Serotype 2 Pathogenicity by Modulating Secretion of Selected Virulence Factors.

Development of a Universal Multi-Epitope Vaccine Candidate Against Streptococcus Suis Infections Using Immunoinformatics Approaches

Immunogenicity and Protective Capacity of Sugar ABC Transporter Substrate-Binding Protein against Streptococcus suis Serotype 2, 7 and 9 Infection in Mice